Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 20;17(11):sfae253.
doi: 10.1093/ckj/sfae253. eCollection 2024 Nov.

Immunosuppression and transplantation-related characteristics affect the difference between eGFR equations based on creatinine compared to cystatin C in kidney transplant recipients

Affiliations

Immunosuppression and transplantation-related characteristics affect the difference between eGFR equations based on creatinine compared to cystatin C in kidney transplant recipients

Lukas Weidmann et al. Clin Kidney J. .

Abstract

Introduction: Previous studies show heterogeneity when applying estimated glomerular filtration (eGFR) equations to kidney transplant recipients (KTRs). However, research on the impact of transplantation-related characteristics on eGFR equations using creatinine (eGFRcr) compared to cystatin C (eGFRcys) is scarce.

Methods: We conducted a comprehensive analysis with three eGFRcr equations (Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2009, European Kidney Function Consortium (EKFC) 2021, kidney recipient specific-glomerular filtration rate KRS-GFR) 2023), comparing them to two eGFRcys (CKD-EPI 2012 and EKFC 2023) in 596 KTRs. Bland-Altman plots demonstrated relative differences according to different eGFR-stages. Multivariable logistic regression identified transplantation-related characteristics independently associated with smaller or greater differences between eGFRcr and eGFRcys equations.

Results: 94.3% of the cohort were White individuals. Median eGFR differed as much as 9 ml/min/1.73 m2 between equations. The median relative differences (Q2) were greater (more negative) when comparing the eGFRcr equations to eGFRcys CKD-EPI 2012, than when comparing them to eGFRcys EKFC 2023 (P < .001). Better average eGFR was associated with smaller mean relative differences in all comparisons but eGFRcr CKD-EPI 2009 with eGFR EKFC 2023 and eGFRcr EKFC 2021 with eGFRcys EKFC 2023. Living kidney donation and belatacept use were independent factors associated with a smaller difference (≥Q3) between eGFRcr and eGFRcys equations, while prednisone use or higher HbA1c were independently associated with a greater difference (≤Q1) between equations.

Conclusion: Different eGFR-stages, donor, or recipient characteristics, along with immunosuppression such as belatacept or prednisone, contribute to differences between eGFRcr and eGFRcys. These effects need to be considered in the clinical management of KTRs.

Keywords: creatinine; cystatin C; estimated glomerular filtration rate; immunosuppression; kidney transplantation.

PubMed Disclaimer

Conflict of interest statement

All authors had no competing interests to declare.

Figures

Graphical Abstract
Graphical Abstract
Figure 1:
Figure 1:
Study flowchart demonstrating the deduction of the study cohort. Exclusion criteria are listed. Abbreviation: TPL, transplantation.
Figure 2:
Figure 2:
Median eGFR values according to different eGFR equations. eGFR values of all individuals (n = 596) based on the different equations assessed in the study. The values are demonstrated as median (with IQR) in boxplots.
Figure 3:
Figure 3:
Median relative differences of all eGFRcr equations compared to the references. Visualization of the median relative differences (with IQR) in all individuals (n = 596) comparing each eGFRcr equation with the two reference equations (eGFRcys CKD-EPI 2012 and EKFC 2023) as forest plots. For all values, please see Appendix 3.
Figure 4:
Figure 4:
Bland–Altman plots of all eGFRcr equations compared to the references. Relative differences of all individuals (n = 596) plotted against the average eGFR between the examined equations. The red line demonstrates a Deming regression of the relative differences, according to different eGFR stages after standardization. The dotted lines visualize the 95% limits of agreement according to the Bland–Altman method. (A) Comparisons between eGFRcr equations and eGFRcys CKD-EPI 2012. (B) Comparisons between eGFRcr equations and eGFRcys EKFC 2023. For the linear functions of all Deming regressions, please see Appendix 4.
Figure 5:
Figure 5:
Associations of interest for smaller or greater differences between eGFRcr equations and references. Associations are demonstrated as forest plots with odds ratios (OR) and 95% CI (low and high). (A) Comparisons between eGFRcr equations and eGFRcys CKD-EPI 2012. (B) Comparisons between eGFRcr equations and eGFRcys EKFC 2023. *P between .05 and .1 (trend, but non-significant). For DKD the reciprocal values (OR, 95% CI) for LKD were calculated. For the exact values, please refer to Table 3. Abbreviations: Bela, belatacept; LKD, living kidney donation; PDN, prednisone; Age, age of the recipient; DKD, deceased kidney donation.

References

    1. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31–41. 10.1159/000180580 - DOI - PubMed
    1. Levey AS, Coresh J, Tighiouart H et al. Measured and estimated glomerular filtration rate: current status and future directions. Nat Rev Nephrol 2020;16:51–64. 10.1038/s41581-019-0191-y - DOI - PubMed
    1. Raynaud M, Aubert O, Reese PP et al. Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation. Kidney Int 2021;99:186–97. 10.1016/j.kint.2020.07.025 - DOI - PubMed
    1. Clayton PA, Lim WH, Wong G et al. Relationship between eGFR decline and hard outcomes after kidney transplants. JASN 2016;27:3440–6. 10.1681/ASN.2015050524 - DOI - PMC - PubMed
    1. Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247–54. 10.7326/0003-4819-145-4-200608150-00004. (Erratum in: Ann Intern Med. 2008 Oct 7;149(7):519. Erratum in: Ann Intern Med. 2021 Apr;174(4):584). - DOI - PubMed